Silence Therapeutics (SLN)
(Delayed Data from NSDQ)
$22.60 USD
+0.41 (1.85%)
Updated May 8, 2024 04:00 PM ET
After-Market: $23.06 +0.46 (2.04%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Brokerage Reports
0 items in cart
Silence Therapeutics PLC Sponsored ADR [SLN]
Reports for Purchase
Showing records 21 - 28 ( 28 total )
Company: Silence Therapeutics PLC Sponsored ADR
Industry: Medical - Drugs
R&D Day Event Highlights Lead RNAi Programs, Broad Pipeline Expansion Underway
Provider: H.C. Wainwright & Co., Inc.
Analyst: TRUCCHIO P
Company: Silence Therapeutics PLC Sponsored ADR
Industry: Medical - Drugs
1H21 results; Lead Programs SLN360 and SLN124, Partnered Programs Progressing; Announces October R&D Day
Provider: H.C. Wainwright & Co., Inc.
Analyst: TRUCCHIO P
Company: Silence Therapeutics PLC Sponsored ADR
Industry: Medical - Drugs
Reports Positive Phase 1 Data in SLN124 Program; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: TRUCCHIO P
Company: Silence Therapeutics PLC Sponsored ADR
Industry: Medical - Drugs
First-in-Human Top-Line Data on Key Assets SLN124 and SLN360 on Track for 2021; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: TRUCCHIO P
Company: Silence Therapeutics PLC Sponsored ADR
Industry: Medical - Drugs
Biotech Should Keep the Wind at its Back in 2021; Top Healthcare Picks
Provider: H.C. Wainwright & Co., Inc.
Analyst: Research Department
Company: Silence Therapeutics PLC Sponsored ADR
Industry: Medical - Drugs
Emerging Leader in Lp(a) Lowering Race; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: TRUCCHIO P
Company: Silence Therapeutics PLC Sponsored ADR
Industry: Medical - Drugs
Impressive Progress on Multiple Fronts
Provider: H.C. Wainwright & Co., Inc.
Analyst: Research Department